Sernova’s Cell Pouch System - An Update on the Path to Insulin Independence

A few weeks ago, Sernova they announced their cell pouch system of islet cell transplants has seen seven people achieve insulin independence and has kept one person off of insulin injections for four years. What does that really mean going forward?

I’m talking to their new CEO Jonathan Rigby and to Frank Shannon, Senior Vice President, Clinical Development and Regulatory Affairs

More about Sernova here

This podcast is not intended as medical advice. If you have those kinds of questions, please contact your health care provider.

Join us at an upcoming Moms' Night Out event!

Please visit our Sponsors & Partners - they help make the show possible!


Omnipod - Simplify Life

Learn about Dexcom

Edgepark Medical Supplies

Check out VIVI Cap to protect your insulin from extreme temperatures

Drive research that matters through the T1D Exchange

The best way to keep up with Stacey and the show is by signing up for our weekly newsletter:

Sign up for our newsletter here

Here's where to find us:

Facebook (Group)

Facebook (Page)

Instagram

Twitter

Check out Stacey's books!

[dovh]

Very exciting! If everything goes well how long before it will be open to the public?

[weinerdad]

I can understand that maybe there's important interaction between beta cells, alpha cells and delta cells inside an islet that are not yet fully understood. But why are they saying glucagon production is restored, when alpha cells don't get destroyed? Glucagon is released just fine by our bodies, so long as the pancreas is not really harmed (ie. pancreatitis, Type 3c). The excess injected insulin seems to overpower the ability to compensate in those situations.